Skip to content
OpenCapital
Get started

Journey Medical Corporation DERM Cash ratio

Cash ratio at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
0.3×0.0×
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
0.3×-0.3×
PTH
Pelthos Therapeutics Inc.PTHS
1.3×+1.3×
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
0.2×-0.4×
HRO
HarrowHROW
1×+0.7×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
5.7×+0.5×

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M—
Free cash flow-$6.0M—

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S3×+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%—
Net margin-14.8%—
FCF margin-43%—

Returns & leverage

See full
Return on equity-36.6%—
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

cash and equivalents/total current liabilities=0.7×

Based on the most recent quarter.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's cash ratio?
Journey Medical Corporation (DERM) reported cash ratio of 0.7× in Q1 2026.
How has Journey Medical Corporation's cash ratio changed year-over-year?
Journey Medical Corporation's cash ratio increased by 37.4% year-over-year, from 0.5× to 0.7×.
What is the long-term trend for Journey Medical Corporation's cash ratio?
Over 5 years (2020 to 2025), Journey Medical Corporation's cash ratio has grown at a 17.0% compound annual growth rate (CAGR), from 0.3× to 0.6×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.